Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023
Thu, March 16, 2023
Wed, March 15, 2023

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Decreased Target to $200 on, Mar 20th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-200-on-mar-20th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $210 to $200 on, Mar 20th, 2023.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 2 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $85 on, Tuesday, February 28th, 2023
  • David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023


These are the ratings of the 5 analyists that currently disagree with Raghuram


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $84 on, Monday, March 13th, 2023
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, February 28th, 2023
  • Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022

Publication Contributing Sources